Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Royalty Pharma raises 2026 guidance after 14% Royalty Receipts growth in Q2Aug 5Quarterly updateRoyalty Pharma plc
GSK wins US approval for Jideytro in previously treated ROS1-positive lung cancerJul 22Regulatory decisionGlaxoSmithKlinezidesamtinib